Late-phase allergic reaction in nasal provocation with fungal allergens

Allergy and Asthma Proceedings

Volumn 29, Issue 1, 2008, Pages 35-39

  Niedoszytko, Marek ^a   Chełmińska, Marta ^a   Chełmiński, Konrad ^a   Knopińska Posłuszny, Wanda ^a   Gruchała Niedoszytko, Marta ^b   Jassem, Ewa ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b Derm Al Allergy Centre   (Poland)

Author keywords

Allergen challenge; Allergic rhinitis; Alternaria; Aspergillus; Fungi; IgE; Late phase reaction; Mold; Nasal provocation; Skin test

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E; TRYPTASE;

ADULT; ARTICLE; EOSINOPHIL; FEMALE; FUNGUS; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; NOSE MUCOSA; NOSE PROVOCATION TEST; PERENNIAL RHINITIS;

ADULT; ALLERGENS; EOSINOPHILS; FEMALE; FUNGI; HUMANS; IMMUNOGLOBULIN E; MALE; MIDDLE AGED; NASAL MUCOSA; NASAL PROVOCATION TESTS; RHINITIS, ALLERGIC, PERENNIAL; TRYPTASES;

EID: 40449141673     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: 10.2500/aap2008.29.3078     Document Type: Article

References (28)

1. Dales R, Cakmak S, Judek S, et al. The role of fungal spores in thunderstorm asthma. Chest 123:745-750, 2003.
2. Garrett M, Rayment P, Hooper M, et al. Indoor airborne fungal spores, house dampness, and associations with environmental factors and respiratory health in children. Clin Exp Allergy 28:459-467, 1998.
3. Lin R, and Williams K. Hypersensitivity to molds in New York City in adults who have asthma. Allergy Asthma Proc 24:13-18, 2003.
4. Zureik M, Neukirch C, Leynaert B, et al. Sensitisation to air-borne moulds and severity of asthma: Cross sectional study from European Community Respiratory Health Survey. BMJ 325:411-414, 2002.
5. Malm L, Gerth-van-Wijk R, and Bachert C. Guidelines for nasal provocations with aspects on nasal patency, airflow, and airflow resistance. Rhinology 37:133-135, 1999.
6. Druce H, and Schumacher MJ. Nasal provocation challenge J Allergy Clin Immunol 86:261-264, 1990.
7. Krouse JH, Shah AG, and Kerswill K. Skin testing in predicting response to nasal provocation with alternaria. Laryngoscope 114:1389-1393, 2004.
8. Chew G, Rogers C, Burge H, et al. Dustborn and airborn fungal propagules represent a different spectrum of fungi with differing relations to home characteristics. Allergy 58:13-20, 2003.
9. Mygind N, Ed. Diagnosis of allergy. In Alergologia. Urban & Partner, Wrocław, 1998. 111-115.
10. Litvyakova L, and Baraniuk J. Nasal provocation testing: A review. Ann Allergy Asthma Immunol 86:355-364, 2001.
11. Lipiec A, Jurkiewicz D, and Rapiejko P. Mould hypersensitivity in allergic patients. Int Rev Allergol Clin Immunol 6:57-62, 2000.
12. Rockwell W. Prompt remediation of water intrusion corrects the resultant mold contamination in a home. Allergy Asthma Proc 26:316-318, 2005.
13. D'Amato G, Chatzigeorgiou G, Corsico R, et al. Evaluation of the prevalence of skin prick test positivity to Alternaria and Cladosporium in patients with suspected respiratory allergy. A European multicenter study promoted by the Subcommittee on Aerobiology and Environmental Aspects of Inhalant Allergens of the European Academy of Allergology and Clinical Immunology. Allergy 52:711-716, 1997.
14. Malling HJ. Diagnosis and immunotherapy of mould allergy. V. Clinical Efficacy and side effects of immunotherapy with Cladosporium herbarum. Allergy 41:507-519, 1986.
15. Cantani A, Businco E, and Maglio A. Alternaria allergy: A three year controlled study in children treated with immunotherapy. Allergol Immunopathol 16:1-4, 1988.
16. Escudero A, Sanchez-Guerrero I, Mora A, et al. Cost-effectiveness of various methods of diagnosing hypersensitivity to Alternaria. Allergol Immunopathol 21:153-175, 1993.
17. Keller H, Madjar J, and Schapowal A. Basophil degranulation test in suspected mould allergy. Laryngol Rhinol Otol 66:484-489, 1987.
18. Katz Y, Verleger H, Barr J, et al. Indoor survey of moulds and prevalence of mould atopy in Israel. Clin Exp Allergy 29:186-192, 1999.
19. Riario-Sforza G, Incorvaia C, Bellotto R, et al. Determination of cut-off positivity values in nasal challenge testing of patients with allergic rhinitis. Allergy Asthma Proc 20:109-114, 1999.
20. Jordan T, Rasp G, Pfrogner E, and Kramer M. An approach of immunoneurological aspects in nasal allergic late phase. Allergy Asthma Proc 26:382-390, 2005.
21. Dharmage S, Bailey M, Raven J, et al. Mouldy houses influence symptoms of asthma among atopic individuals. Clin Exp Allergy 32:714-720, 2002.
22. Ward G, Karlsson G, Rose G, and Platts-Mills T. Trichophyton asthma: Sensitisation of bronchi and upper airways to dermatophyte antigen. Lancet 22:859-862, 1989.
23. Bogacka E, and Malolepszy J. Znaczenie kliniczne alergii na antygeny grzybów. Alergia 2002:20-23.
24. Kramer M, Burow G, Pfrogner E, and Rasp G. In vitro diagnosis of chronic nasal inflammation. Clin Exp Allergy 34:1086-1092, 2004.
25. Klimek L, and Rasp G. Norm values for eosinophil cationic protein in nasal secretions: Influence of specimen collection. Clin Exp Allergy 29:367-374, 1999.
26. Makkonen K, Viitala K, Parkilla S, and Niemela O. Serum IgG and IgE antibodies against mould-derived antigens in patients with symptoms of hypersensitivity. Clinica Chimica Acta 305: 89-98, 2001.
27. Oldenbeuving N, KleinJan A, Mulder P, et al. Evaluation of an intranasal house dust mite provocation model as a tool In clinical research. Allergy 60:751-759, 2005.
28. Lonnkvist K, Moshfegh A, Pedroletti C, et al. Increased eosinophil transmigration after nasal allergen challenge in children with allergic asthma and rhinitis. Allergy 57:1200-1204, 2002.